vs
Side-by-side financial comparison of Essent Group Ltd. (ESNT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $312.4M, roughly 1.6× Essent Group Ltd.). Essent Group Ltd. runs the higher net margin — 49.6% vs 6.8%, a 42.8% gap on every dollar of revenue. On growth, Essent Group Ltd. posted the faster year-over-year revenue change (-0.8% vs -1.7%). Over the past eight quarters, Essent Group Ltd.'s revenue compounded faster (2.3% CAGR vs -0.1%).
Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ESNT vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $312.4M | $493.8M |
| Net Profit | $155.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 59.1% | 9.9% |
| Net Margin | 49.6% | 6.8% |
| Revenue YoY | -0.8% | -1.7% |
| Net Profit YoY | -7.7% | 10.5% |
| EPS (diluted) | $1.61 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.4M | $493.8M | ||
| Q3 25 | $311.8M | $492.9M | ||
| Q2 25 | $319.1M | $468.8M | ||
| Q1 25 | $317.6M | $458.4M | ||
| Q4 24 | $315.0M | $502.4M | ||
| Q3 24 | $316.6M | $511.2M | ||
| Q2 24 | $312.9M | $504.3M | ||
| Q1 24 | $298.4M | $495.1M |
| Q4 25 | $155.0M | $33.7M | ||
| Q3 25 | $164.2M | $71.7M | ||
| Q2 25 | $195.3M | $39.3M | ||
| Q1 25 | $175.4M | $20.7M | ||
| Q4 24 | $167.9M | $30.5M | ||
| Q3 24 | $176.2M | $19.4M | ||
| Q2 24 | $203.6M | $-153.0M | ||
| Q1 24 | $181.7M | $4.0M |
| Q4 25 | 59.1% | 9.9% | ||
| Q3 25 | 63.9% | 13.8% | ||
| Q2 25 | 72.4% | 12.8% | ||
| Q1 25 | 65.2% | 7.0% | ||
| Q4 24 | 61.9% | 7.8% | ||
| Q3 24 | 65.6% | 6.6% | ||
| Q2 24 | 76.4% | -31.3% | ||
| Q1 24 | 71.6% | 3.2% |
| Q4 25 | 49.6% | 6.8% | ||
| Q3 25 | 52.7% | 14.5% | ||
| Q2 25 | 61.2% | 8.4% | ||
| Q1 25 | 55.2% | 4.5% | ||
| Q4 24 | 53.3% | 6.1% | ||
| Q3 24 | 55.6% | 3.8% | ||
| Q2 24 | 65.1% | -30.3% | ||
| Q1 24 | 60.9% | 0.8% |
| Q4 25 | $1.61 | $0.40 | ||
| Q3 25 | $1.67 | $0.84 | ||
| Q2 25 | $1.93 | $0.46 | ||
| Q1 25 | $1.69 | $0.24 | ||
| Q4 24 | $1.59 | $0.37 | ||
| Q3 24 | $1.65 | $0.23 | ||
| Q2 24 | $1.91 | $-1.84 | ||
| Q1 24 | $1.70 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $5.8B | $865.9M |
| Total Assets | $7.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $5.8B | $865.9M | ||
| Q3 25 | $5.7B | $890.7M | ||
| Q2 25 | $5.7B | $833.8M | ||
| Q1 25 | $5.7B | $789.2M | ||
| Q4 24 | $5.6B | $764.9M | ||
| Q3 24 | $5.6B | $732.5M | ||
| Q2 24 | $5.4B | $706.5M | ||
| Q1 24 | $5.2B | $856.2M |
| Q4 25 | $7.4B | $2.2B | ||
| Q3 25 | $7.4B | $2.2B | ||
| Q2 25 | $7.2B | $2.1B | ||
| Q1 25 | $7.2B | $2.0B | ||
| Q4 24 | $7.1B | $2.2B | ||
| Q3 24 | $7.1B | $2.1B | ||
| Q2 24 | $6.7B | $2.0B | ||
| Q1 24 | $6.6B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $856.1M | $114.1M |
| Free Cash FlowOCF − Capex | $848.7M | — |
| FCF MarginFCF / Revenue | 271.7% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 5.52× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $856.1M | $114.1M | ||
| Q3 25 | $215.9M | $137.3M | ||
| Q2 25 | $189.5M | $137.2M | ||
| Q1 25 | $221.6M | $-117.5M | ||
| Q4 24 | $861.5M | $133.0M | ||
| Q3 24 | $229.2M | $91.8M | ||
| Q2 24 | $188.7M | $107.0M | ||
| Q1 24 | $216.9M | $-125.2M |
| Q4 25 | $848.7M | — | ||
| Q3 25 | $210.6M | — | ||
| Q2 25 | $188.8M | — | ||
| Q1 25 | $221.3M | — | ||
| Q4 24 | $854.8M | — | ||
| Q3 24 | $228.7M | — | ||
| Q2 24 | $187.6M | — | ||
| Q1 24 | $212.5M | — |
| Q4 25 | 271.7% | — | ||
| Q3 25 | 67.5% | — | ||
| Q2 25 | 59.2% | — | ||
| Q1 25 | 69.7% | — | ||
| Q4 24 | 271.3% | — | ||
| Q3 24 | 72.2% | — | ||
| Q2 24 | 60.0% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 5.52× | 3.39× | ||
| Q3 25 | 1.31× | 1.91× | ||
| Q2 25 | 0.97× | 3.49× | ||
| Q1 25 | 1.26× | -5.66× | ||
| Q4 24 | 5.13× | 4.36× | ||
| Q3 24 | 1.30× | 4.72× | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 1.19× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESNT
| Mortgage Insurance Segment | $192.4M | 62% |
| Other | $120.0M | 38% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
